On June 24 and 25, Metronik joined leading pharmaceutical manufacturers at PharmaTalk 2026 in Brussels, the annual forum for manufacturing excellence, digitalization, and regulatory compliance.
Saša Sokolić, Director of Business Development and Sales at Metronik, used his session to name a blind spot most manufacturers don’t know they have: they never capture the full truth of what happens on their shop floor.
Today’s plants collect real-time measurements and alarms and events. But the final batch report generated on the machine, the record that actually represents how a batch was made and how it turned out, is routinely discarded. Manufacturing records are then rebuilt from raw equipment tags. The most authoritative version of the truth is thrown away and reconstructed after the fact.
Saša’s argument: capture the batch report generated at the source, in its validated form, and hand the MES only what it needs as a contextualized model, already shaped to fit. That is what real data integrity, traceability, and GMP compliance rest on, not a reconstruction stitched together from raw signals.
The conversations that followed confirmed it: the gap is widely felt and rarely named. Closing it is where the next real gains in pharma data integrity will come from.
